BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 9231649)

  • 1. Preserved GLP-I effects on glycogen synthase a activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats.
    Morales M; López-Delgado MI; Alcántara A; Luque MA; Clemente F; Márquez L; Puente J; Viñambres C; Malaisse WJ; Villanueva-Peñacarrillo ML; Valverde I
    Diabetes; 1997 Aug; 46(8):1264-9. PubMed ID: 9231649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 agonist and exendin(9-39)amide antagonist of the GLP-1(7-36)amide effects in liver and muscle.
    Alcántara AI; Morales M; Delgado E; López-Delgado MI; Clemente F; Luque MA; Malaisse WJ; Valverde I; Villanueva-Peñacarrillo ML
    Arch Biochem Biophys; 1997 May; 341(1):1-7. PubMed ID: 9143346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats.
    López-Delgado MI; Morales M; Villanueva-Peñacarrillo ML; Malaisse WJ; Valverde I
    Endocrinology; 1998 Jun; 139(6):2811-7. PubMed ID: 9607788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle.
    Villanueva-Peñacarrillo ML; Alcántara AI; Clemente F; Delgado E; Valverde I
    Diabetologia; 1994 Nov; 37(11):1163-6. PubMed ID: 7867889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide 1: a potent glycogenic hormone.
    Valverde I; Morales M; Clemente F; López-Delgado MI; Delgado E; Perea A; Villanueva-Peñacarrillo ML
    FEBS Lett; 1994 Aug; 349(2):313-6. PubMed ID: 8050588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased insulin action in cultured hepatocytes from rats with diabetes induced by neonatal streptozotocin.
    Melin B; Caron M; Cherqui G; Blivet MJ; Bailbe D; Picard J; Capeau J; Portha B
    Endocrinology; 1991 Apr; 128(4):1693-701. PubMed ID: 1848501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihyperglycemic action of isoferulic acid in streptozotocin-induced diabetic rats.
    Liu IM; Hsu FL; Chen CF; Cheng JT
    Br J Pharmacol; 2000 Feb; 129(4):631-6. PubMed ID: 10683186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of glycogen metabolism in primary cultures of rat hepatocytes. Restoration of acute effects of insulin and glucose in cells from diabetic rats.
    Miller TB; Garnache AK; Cruz J; McPherson RK; Wolleben C
    J Biol Chem; 1986 Jan; 261(2):785-90. PubMed ID: 3079760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats.
    Farrace S; Rossetti L
    Diabetes; 1992 Nov; 41(11):1453-63. PubMed ID: 1397721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium restores glycogen synthesis from glucose in hepatocytes from diabetic rats.
    Rodriguez-Gil JE; Guinovart JJ; Bosch F
    Arch Biochem Biophys; 1993 Mar; 301(2):411-5. PubMed ID: 8460950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.
    Burcelin R; Eddouks M; Maury J; Kande J; Assan R; Girard J
    Diabetologia; 1995 Mar; 38(3):283-90. PubMed ID: 7758874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose activation of liver glycogen synthase. Insulin-mediated restoration of glucose effect in diabetic rats is blocked by protein synthesis inhibitor.
    Miller TB
    Biochim Biophys Acta; 1979 Feb; 583(1):36-46. PubMed ID: 217447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthesis by hepatocytes from diabetic rats.
    Golden S; Wals PA; Okajima F; Katz J
    Biochem J; 1979 Sep; 182(3):727-34. PubMed ID: 160223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
    Rossetti L; Lauglin MR
    J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal diabetes in rats and its effect on placental glycogen.
    Barash V; Gutman A; Shafrir E
    Diabetologia; 1985 Apr; 28(4):244-9. PubMed ID: 3926571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver and muscle insulin sensitivity, glycogen concentration and glycogen synthase activity in a rat model of non-insulin-dependent diabetes.
    Kruszynska YT; Home PD
    Diabetologia; 1988 May; 31(5):304-9. PubMed ID: 3135217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthesis from glucose and fructose in hepatocytes from diabetic rats.
    Ciudad CJ; Carabaza A; Guinovart JJ
    Arch Biochem Biophys; 1988 Dec; 267(2):437-47. PubMed ID: 3145717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures.
    Henry RR; Abrams L; Nikoulina S; Ciaraldi TP
    Diabetes; 1995 Aug; 44(8):936-46. PubMed ID: 7622000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defect of an early event of glucose metabolism in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty (OLETF) rat, a non-insulin-dependent diabetes mellitus (NIDDM) model.
    Sato T; Magata K; Koga N; Mitsumoto Y
    Biochem Biophys Res Commun; 1998 Apr; 245(2):378-81. PubMed ID: 9571158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.